VERO insider trading
OTC Markets OTCPK HealthcareVenus Concept Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About Venus Concept Inc.
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, a portable and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF combined with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, flanks, back, and thighs in individuals with a body mass index BMI of 30 or less; Venus Glow, a Motorized dermabrasion device used to improve skin appearance; and NeoGraft, a hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.
Company website: www.venus.ai
VERO insider activity at a glance
FilingIQ has scored 175 insider transactions for VERO since Nov 7, 2019. The most recent filing in our index is dated Mar 26, 2026.
Across the full history, 38 open-market purchases
and 53 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on VERO insider trades is 55.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for VERO?
- FilingIQ tracks 175 Form 4 insider transactions for VERO (Venus Concept Inc.), covering filings from Nov 7, 2019 onwards. 9 of those were filed in the last 90 days.
- Are VERO insiders net buyers or net sellers?
- Across the full Form 4 history for VERO, 38 transactions (22%) were open-market purchases and 53 (30%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does VERO insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is VERO in?
- Venus Concept Inc. (VERO) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $576328.
Methodology & sources
Every VERO insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.